Intelerad Ambra PACS software recalled for incomplete imaging studies
Certain versions of Ambra PACS (InteleShare) imaging software have two issues: studies may be duplicated incompletely, and images may be archived incompletely. A reader could act on an incomplete examination, which could lead to misdiagnosis, delayed diagnosis or treatment, or the need for additional imaging.
From the FDA notice · Read the official notice ↗ · All Intelerad recalls
What to do
- Contact Intelerad Medical Systems Incorporated about the affected software versions before relying on studies from them.
- Check your installed versions and the lot numbers against the notice's list, such as 122-08988176 and 000-08975894.
- The notice does not specify a remedy; ask Intelerad Medical Systems Incorporated how to get a fix or update.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Ambra PACS (InteleShare) System, Image Processing, Radiological
- Sold in
- Nationwide
- Made for
- All ages (0 months and older)
Details
- Units affected
- 771 US; 60 OUS
- Illnesses reported
- None reported
- Manufactured in
- 800, Boul. de Maisonneuve Est, 14th floor, Montreal, Canada
- Classification
- Class II
- Recall number
- Z-0527-2027
In the FDA's words
- Description
- Ambra PACS (InteleShare) System, Image Processing, Radiological Two issues affect certain versions of the software: 1. Incomplete study duplication, and 2. Incomplete image archival. Either issue could result in a reader acting on an incomplete examination, which could result in misdiagnosis, delay in diagnosis or treatment, or require additional imaging. Lot# T1P0113C: Exp. 28-Feb-29 Lot# T1P0612C: Exp. 31-Oct-28 Distribution: Worldwide distribution - US Nationwide and the countries of Australia, Belgium, Bermuda, Brazil, Canada, France, Germany, India, Ireland, Italy, Jamaica, New Zealand, Norway, Sweden, Switzerland, and United Kingdom. Affected quantity: 771 US; 60 OUS
- Hazard
- Two issues affect certain versions of the software: 1. Incomplete study duplication, and 2. Incomplete image archival. Either issue could result in a reader acting on an incomplete examination, which could result in misdiagnosis, delay in diagnosis or treatment, or require additional imaging.
More from Intelerad
See all- Intelerad IntelePACS software recalled for risk of deleting studies
ModerateFDANov 20, 2026
- Intelerad IntelePACS software recalled for cybersecurity risk
ModerateFDANov 4, 2026
- IntelePACS medical imaging system recalled for image display mismatch
ModerateFDAOct 21, 2026